Welcome!

News Feed Item

Arterial Calcification Global Clinical Trials Review, H2, 2014

NEW YORK, Sept. 2, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Arterial Calcification Global Clinical Trials Review, H2, 2014

http://www.reportlinker.com/p02353405/Arterial-Calcification-Global-Clinical-Trials-Review-H2-2014.html

Arterial Calcification Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, "Arterial Calcification Global Clinical Trials Review, H2, 2014" provides data on the Arterial Calcification clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Arterial Calcification. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Arterial Calcification. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2

Introduction 5
Arterial Calcification 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Central and South America 12
Clinical Trials by G7 Countries: Proportion of Arterial Calcification to Cardiovascular Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Arterial Calcification to Cardiovascular Clinical Trials 16
Clinical Trials by Phase in E7 Countries 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Clinical Trials by End Point Status 21
Subjects Recruited Over a Period of Time 22
Clinical Trials by Sponsor Type 23
Prominent Sponsors 24
Top Companies Participating in Arterial Calcification Therapeutics Clinical Trials 25
Prominent Drugs 26
Clinical Trial Profiles 27
Clinical Trial Overview of Top Companies 27
Medestea Internazionale S.p.A. 27
Clinical Trial Overview of Medestea Internazionale S.p.A. 27
Amgen Inc. 28
Clinical Trial Overview of Amgen Inc. 28
Clinical Trial Overview of Top Institutes / Government 29
National Heart, Lung, and Blood Institute 29
Clinical Trial Overview of National Heart, Lung, and Blood Institute 29
Medical University of Lodz 30
Clinical Trial Overview of Medical University of Lodz 30
Romanian Society of Nephrology 31
Clinical Trial Overview of Romanian Society of Nephrology 31
Okayama University 32
Clinical Trial Overview of Okayama University 32
Kingston General Hospital 33
Clinical Trial Overview of Kingston General Hospital 33
Osaka University 34
Clinical Trial Overview of Osaka University 34
Aarhus University 35
Clinical Trial Overview of Aarhus University 35
Mayo Clinic in Rochester 36
Clinical Trial Overview of Mayo Clinic in Rochester 36
National Taiwan University Hospital 37
Clinical Trial Overview of National Taiwan University Hospital 37
University of Kentucky 38
Clinical Trial Overview of University of Kentucky 38
Five Key Clinical Profiles 39
Appendix 66
Abbreviations 66
Definitions 66
Research Methodology 67
Secondary Research 67
About GlobalData 68
Contact Us 68
Disclaimer 68
Source 68

List of Tables

Arterial Calcification Therapeutics, Global, Clinical Trials by Region, 2014* 6
Arterial Calcification Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Arterial Calcification Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Arterial Calcification Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Arterial Calcification Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 10
Arterial Calcification Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Arterial Calcification Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 12
Proportion of Arterial Calcification to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 13
Arterial Calcification Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Arterial Calcification Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Arterial Calcification to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 16
Arterial Calcification Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 17
Arterial Calcification Therapeutics, Global, Clinical Trials by Phase, 2014* 18
Arterial Calcification Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 19
Arterial Calcification Therapeutics, Global, Clinical Trials by Trial Status, 2014* 20
Arterial Calcification Therapeutics Clinical Trials, Global, by End Point Status, 2014* 21
Arterial Calcification Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 22
Arterial Calcification Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 23
Arterial Calcification Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 24
Arterial Calcification Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 25
Arterial Calcification Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 26
Arterial Calcification Therapeutics Clinical Trials Market, Global, Clinical Trials by Medestea Internazionale S.p.A., 2014* 27
Arterial Calcification Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014* 28
Arterial Calcification Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014* 29
Arterial Calcification Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Lodz, 2014* 30
Arterial Calcification Therapeutics Clinical Trials Market, Global, Clinical Trials by Romanian Society of Nephrology, 2014* 31
Arterial Calcification Therapeutics Clinical Trials Market, Global, Clinical Trials by Okayama University, 2014* 32
Arterial Calcification Therapeutics Clinical Trials Market, Global, Clinical Trials by Kingston General Hospital, 2014* 33
Arterial Calcification Therapeutics Clinical Trials Market, Global, Clinical Trials by Osaka University, 2014* 34
Arterial Calcification Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University, 2014* 35
Arterial Calcification Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic in Rochester, 2014* 36
Arterial Calcification Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2014* 37
Arterial Calcification Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Kentucky, 2014* 38

List of Figures

Arterial Calcification Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Arterial Calcification Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Arterial Calcification Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Arterial Calcification Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 9
Arterial Calcification Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 10
Arterial Calcification Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 11
Proportion of Arterial Calcification to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 13
Arterial Calcification Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Arterial Calcification Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Arterial Calcification to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 16
Arterial Calcification Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 17
Arterial Calcification Therapeutics, Global, Clinical Trials by Phase (%), 2014* 18
Arterial Calcification Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 19
Arterial Calcification Therapeutics, Global, Clinical Trials by Trial Status, 2014* 20
Arterial Calcification Therapeutics Clinical Trials, Global, by End Point Status, 2014* 21
Arterial Calcification Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 22
Arterial Calcification Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 23
Arterial Calcification Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 24
Arterial Calcification Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 25
Arterial Calcification Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 26
GlobalData Methodology 67

To order this report: Arterial Calcification Global Clinical Trials Review, H2, 2014
http://www.reportlinker.com/p02353405/Arterial-Calcification-Global-Clinical-Trials-Review-H2-2014.html

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
All organizations that did not originate this moment have a pre-existing culture as well as legacy technology and processes that can be more or less amenable to DevOps implementation. That organizational culture is influenced by the personalities and management styles of Executive Management, the wider culture in which the organization is situated, and the personalities of key team members at all levels of the organization. This culture and entrenched interests usually throw a wrench in the work...
Dion Hinchcliffe is an internationally recognized digital expert, bestselling book author, frequent keynote speaker, analyst, futurist, and transformation expert based in Washington, DC. He is currently Chief Strategy Officer at the industry-leading digital strategy and online community solutions firm, 7Summits.
Bill Schmarzo, author of "Big Data: Understanding How Data Powers Big Business" and "Big Data MBA: Driving Business Strategies with Data Science," is responsible for setting the strategy and defining the Big Data service offerings and capabilities for EMC Global Services Big Data Practice. As the CTO for the Big Data Practice, he is responsible for working with organizations to help them identify where and how to start their big data journeys. He's written several white papers, is an avid blogge...
DXWorldEXPO LLC announced today that Dez Blanchfield joined the faculty of CloudEXPO's "10-Year Anniversary Event" which will take place on November 11-13, 2018 in New York City. Dez is a strategic leader in business and digital transformation with 25 years of experience in the IT and telecommunications industries developing strategies and implementing business initiatives. He has a breadth of expertise spanning technologies such as cloud computing, big data and analytics, cognitive computing, m...
22nd International Cloud Expo, taking place June 5-7, 2018, at the Javits Center in New York City, NY, and co-located with the 1st DXWorld Expo will feature technical sessions from a rock star conference faculty and the leading industry players in the world. Cloud computing is now being embraced by a majority of enterprises of all sizes. Yesterday's debate about public vs. private has transformed into the reality of hybrid cloud: a recent survey shows that 74% of enterprises have a hybrid cloud ...
As DevOps methodologies expand their reach across the enterprise, organizations face the daunting challenge of adapting related cloud strategies to ensure optimal alignment, from managing complexity to ensuring proper governance. How can culture, automation, legacy apps and even budget be reexamined to enable this ongoing shift within the modern software factory?
In past @ThingsExpo presentations, Joseph di Paolantonio has explored how various Internet of Things (IoT) and data management and analytics (DMA) solution spaces will come together as sensor analytics ecosystems. This year, in his session at @ThingsExpo, Joseph di Paolantonio from DataArchon, added the numerous Transportation areas, from autonomous vehicles to “Uber for containers.” While IoT data in any one area of Transportation will have a huge impact in that area, combining sensor analytic...
Bill Schmarzo, author of "Big Data: Understanding How Data Powers Big Business" and "Big Data MBA: Driving Business Strategies with Data Science," is responsible for setting the strategy and defining the Big Data service offerings and capabilities for EMC Global Services Big Data Practice. As the CTO for the Big Data Practice, he is responsible for working with organizations to help them identify where and how to start their big data journeys. He's written several white papers, is an avid blogge...
Charles Araujo is an industry analyst, internationally recognized authority on the Digital Enterprise and author of The Quantum Age of IT: Why Everything You Know About IT is About to Change. As Principal Analyst with Intellyx, he writes, speaks and advises organizations on how to navigate through this time of disruption. He is also the founder of The Institute for Digital Transformation and a sought after keynote speaker. He has been a regular contributor to both InformationWeek and CIO Insight...
Michael Maximilien, better known as max or Dr. Max, is a computer scientist with IBM. At IBM Research Triangle Park, he was a principal engineer for the worldwide industry point-of-sale standard: JavaPOS. At IBM Research, some highlights include pioneering research on semantic Web services, mashups, and cloud computing, and platform-as-a-service. He joined the IBM Cloud Labs in 2014 and works closely with Pivotal Inc., to help make the Cloud Found the best PaaS.
It is of utmost importance for the future success of WebRTC to ensure that interoperability is operational between web browsers and any WebRTC-compliant client. To be guaranteed as operational and effective, interoperability must be tested extensively by establishing WebRTC data and media connections between different web browsers running on different devices and operating systems. In his session at WebRTC Summit at @ThingsExpo, Dr. Alex Gouaillard, CEO and Founder of CoSMo Software, presented ...
@DevOpsSummit at Cloud Expo, taking place November 12-13 in New York City, NY, is co-located with 22nd international CloudEXPO | first international DXWorldEXPO and will feature technical sessions from a rock star conference faculty and the leading industry players in the world.
One of the biggest challenges with adopting a DevOps mentality is: new applications are easily adapted to cloud-native, microservice-based, or containerized architectures - they can be built for them - but old applications need complex refactoring. On the other hand, these new technologies can require relearning or adapting new, oftentimes more complex, methodologies and tools to be ready for production. In his general session at @DevOpsSummit at 20th Cloud Expo, Chris Brown, Solutions Marketi...
In a world where the internet rules all, where 94% of business buyers conduct online research, and where e-commerce sales are poised to fall between $427 billion and $443 billion by the end of this year, we think it's safe to say that your website is a vital part of your business strategy. Whether you're a B2B company, a local business, or an e-commerce site, digital presence is key to maintain in your drive towards success. Digital Performance will take priority in 2018 for the following reason...
At the keynote this morning we spoke about the value proposition of Nutanix, of having a DevOps culture and a mindset, and the business outcomes of achieving agility and scale, which everybody here is trying to accomplish," noted Mark Lavi, DevOps Solution Architect at Nutanix, in this SYS-CON.tv interview at @DevOpsSummit at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.